Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression

  • Géraldine Lescaille1,
  • Suzanne Menashi2,
  • Bénédicte Cavelier-Balloy3,
  • Farah Khayati1,
  • Cathy Quemener1,
  • Marie Pierre Podgorniak4,
  • Benyoussef Naïmi5,
  • Fabien Calvo1, 6,
  • Céleste Lebbe6, 7 and
  • Samia Mourah1, 4, 6, 8Email author
BMC Cancer201212:115

DOI: 10.1186/1471-2407-12-115

Received: 9 August 2011

Accepted: 23 March 2012

Published: 23 March 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
9 Aug 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
6 Oct 2011 Reviewed Reviewer Report - Stanley Zucker
10 Oct 2011 Reviewed Reviewer Report - Nadarajah Vigneswaran
12 Oct 2011 Reviewed Reviewer Report - Wolfgang Zacharias
14 Oct 2011 Reviewed Reviewer Report - Kazuki Nabeshima
28 Dec 2011 Author responded Author comments - Samia Mourah
Resubmission - Version 3
28 Dec 2011 Submitted Manuscript version 3
4 Jan 2012 Reviewed Reviewer Report - Stanley Zucker
6 Jan 2012 Reviewed Reviewer Report - Nadarajah Vigneswaran
11 Jan 2012 Reviewed Reviewer Report - Wolfgang Zacharias
23 Jan 2012 Reviewed Reviewer Report - Kazuki Nabeshima
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
23 Mar 2012 Editorially accepted
23 Mar 2012 Article published 10.1186/1471-2407-12-115

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Inserm, UMR-S 940
(2)
CNRS, EAC 7149, Laboratoire CRRET, Université 12
(3)
Cabinet de Dermatopathologie 35, avenue Mathurin Moreau
(4)
AP-HP, Hôpital Saint-Louis, Laboratory of Pharmacology
(5)
Université Paris 12
(6)
Université Paris 7- IUH
(7)
Département de Dermatologie, hôpital Saint Louis
(8)
Laboratoire de Pharmacologie and INSERM U940, Hôpital Saint-Louis, 27, rue Juliette Dodu

Advertisement